Research – New Indian Express

express news service

BHUBANESWAR: Irritable bowel syndrome (IBS) may not be a life-threatening disease, but it has a major impact on the healthcare system and society. A recent study conducted in Odisha found that the direct and indirect costs of moderate to severe irritable bowel syndrome are high, with the largest driver of direct costs being hospitalization, which impacts people’s financial status. It turns out.

IBS is one of the most common functional bowel diseases, with a prevalence of approximately 10 to 15 percent. The chronic nature and high prevalence impose a high economic and social burden. A group of seven senior gastroenterologists in the state studied the annual direct and indirect costs and social impact of patients diagnosed with IBS.

The study, published in Gastroenterology, the influential official medical journal of the American College of Gastroenterology, reveals that IBS impacts the financial status of half of patients and the professional lives of most patients. did. The total annual cost per patient was estimated at $70,560. Medical costs per patient were estimated at $42,846, accounting for 60.72% of the total costs, while transportation and food costs were estimated at $9,939, accounting for 14.1% of the total costs.

Productivity losses accounted for an average of $17,805 and 25.23% of total annual costs. Additionally, 55.8 percent of patients surveyed by the research team claimed to have used their savings for illness-related expenses. An analysis of the impact of IBS on social life found that 97.6 percent of patients’ jobs were affected by the disease, and 89 percent of patients avoided outdoor meetings.

Dr. Ayaskanta Singh, the study’s principal investigator, said IBS imposes a significant economic burden on patients and the healthcare system. “More than three-quarters of the total annual cost of IBS consists of direct expenditures such as consultation fees, drug costs, and travel expenses,” said Dr. Singh, senior consultant at SUM Ultimate Medicare.

The prevalence of IBS is high in the coastal regions of Odisha and West Bengal, with approximately 25% of patients developing post-infectious (PI)-IBS after 6 months. Young age, long duration of gastrointestinal infection, and abdominal pain were independent risk factors. This study suggests that the disease burden of IBS is significant, as all subtypes of IBS require similar levels of medical care.

Not fatal, but costly

• IBS is one of the most common functional bowel diseases, with a prevalence of approximately 10 to 15 percent.
• The total annual cost per patient is estimated at `70,560
• Medical costs per patient are estimated to be 42,846, accounting for 60.72% of total medical costs

</p> <p>BHUBANESWAR: Irritable bowel syndrome (IBS) may not be a life-threatening disease, but it has a major impact on the healthcare system and society. A recent study conducted in Odisha found that the direct and indirect costs of moderate to severe irritable bowel syndrome are high, with the largest driver of direct costs being hospitalization, which impacts people’s financial status. It turns out. IBS is one of the most common functional bowel diseases, with a prevalence of approximately 10 to 15 percent. The chronic nature and high prevalence impose a high economic and social burden. A group of seven senior gastroenterologists in the state studied the annual direct and indirect costs and social impact of patients diagnosed with IBS. The study, published in Gastroenterology, the influential official medical journal of the American College of Gastroenterology, reveals that IBS impacts the financial status of half of patients and the professional lives of most patients. did. The total annual cost per patient was estimated at $70,560. Medical costs per patient were estimated at $42,846, accounting for 60.72% of the total costs, while transportation and food costs were estimated at $9,939, accounting for 14.1% of the total costs. googletag.cmd.push(function() {googletag.display(‘div-gpt-ad-8052921-2′); }); The average productivity loss is $17,805, which is 25.23 percent of the total annual cost. To do. Additionally, 55.8 percent of patients surveyed by the research team claimed to have used their savings for illness-related expenses. An analysis of the impact of IBS on social life found that 97.6 percent of patients’ jobs were affected by the disease, and 89 percent of patients avoided outdoor meetings. Dr. Ayaskanta Singh, the study’s principal investigator, said IBS imposes a significant economic burden on patients and the healthcare system. “More than three-quarters of the total annual cost of IBS consists of direct expenditures such as consultation fees, drug costs, and travel expenses,” said Dr. Singh, senior consultant at SUM Ultimate Medicare. The prevalence of IBS is high in the coastal regions of Odisha and West Bengal, with approximately 25% of patients developing post-infectious (PI)-IBS after 6 months. Young age, long duration of gastrointestinal infection, and abdominal pain were independent risk factors. This study suggests that the disease burden of IBS is substantial, as all subtypes of IBS require similar levels of medical care.Non-fatal but costly  With a prevalence of approximately 10-15%, IBS is one of the most common functional bowel diseases  Total annual cost per patient is estimated at 70,560  The medical cost per patient is estimated at 42,846 60.72 percent of the total cost</p> <p>